Coexpression of RTI40 with alveolar epithelial type II cell proteins in lungs following injury: identification of alveolar intermediate cell types.
Injured alveolar epithelial type (AT) I cells are replaced following the proliferation and transformation of ATII cells to new ATI cells. RTI(40) is an ATI cell-specific protein required for normal lung development. We hypothesized that intermediate cell types in the ATII-to-ATI cell transformation would coexpress RTI(40) and ATII cell-selective proteins. To test this hypothesis, we used a rat model of Staphylococcus aureus-induced acute lung injury and a panel of ATI and ATII cell-specific and -selective antibodies. S. aureus induced an acute inflammatory reaction that was resolving by day 3 postinoculation. At day 3 postinoculation, the alveolar wall was thickened secondary to ATII cell hyperplasia. With the use of confocal microscopy, there was a fivefold increase in the fractional surface area of alveolar walls stained with ATII cell membrane proteins (RTII(70) and MMC4) and a decrease in the fractional surface area associated with RTI(40)-expressing cells. S. aureus-treated lungs also contained unique cell types that coexpressed the RTI(40) and ATII markers RTI(40)/MMC4/RTII(70)- and RTI(40)/MMC4-positive cells. These cells were not observed in control lungs. RTI(40)/MMC4-positive cells were also found in cultured ATII cells before they transformed to an ATI-like phenotype. Our data suggest that RTI(40)/MMC4/RTII(70)- and RTI(40)/MMC4-positive cells are intermediates in the ATII-to-ATI cell transformation. These data also suggest that the coexpression of RTI(40) with ATII cell proteins may be used to identify and investigate ATII cell transdifferentiation to ATI cells following injury.
Clegg
Gareth R
GR
Edinburgh Medical Research Council Centre for Inflammation Research, University of Edinburgh, Scotland, UK.
Tyrrell
Christine
C
McKechnie
Stuart R
SR
Beers
Michael F
MF
Harrison
David
D
McElroy
Mary C
MC
D000818:Animals; D000911:Antibodies, Monoclonal / Q000378:metabolism*; D000954:Antigens, Surface / Q000378:metabolism*; D051402:Aquaporin 5; D020346:Aquaporins / Q000378:metabolism; D015824:Blood-Air Barrier; D002478:Cells, Cultured; D008168:Lung / Q000473:pathology; D008297:Male; D008562:Membrane Glycoproteins; D008565:Membrane Proteins / Q000378:metabolism*; D010641:Phenotype; D018410:Pneumonia, Bacterial / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D011650:Pulmonary Alveoli / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013203:Staphylococcal Infections; D013997:Time Factors; D000098853:Podoplanin
D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D051402:Aquaporin 5; D020346:Aquaporins; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; C496040:Aqp5 protein, rat; C427585:MMC4 antigen, rat; C092025:Pdpn protein, rat; D000098853:Podoplanin; C448599:RTII70 protein, rat